PTGX
Protagonist Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$92.36
-3.06 ▼ -3.21%
🌙 3월 13일 6:10 PM ET (한국 3/14 07:10)
$92.01
-0.35 ▼ -0.38%
| Index | RUT | P/E | - | EPS (ttm) | -2.04 | Insider Own | 5.99% | Shs Outstand | 0.06B | Perf Week | 0.29% |
| Market Cap | 5.89B | Forward P/E | - | EPS next Y | -121.02% | Insider Trans | -5.6% | Shs Float | 0.06B | Perf Month | 10.62% |
| Enterprise Value | 5.34B | PEG | - | EPS next Q | -0.45 | Inst Own | 108.2% | Short Float | 13.66% | Perf Quarter | 1.07% |
| Income | -0.13B | P/S | 128.06 | EPS this Y | 249.28% | Inst Trans | 1.96% | Short Ratio | 10.93 | Perf Half Y | 54.76% |
| Sales | 0.05B | P/B | 9.4 | EPS next 5Y | - | ROA | -18.37% | Short Interest | 8.19M | Perf YTD | 5.75% |
| Book/sh | 9.82 | P/C | 10.39 | EPS past 3/5Y | 7.63% -1.26% | ROE | -20.18% | 52W High | -6.06% ($98.32) | Perf Year | 68.23% |
| Cash/sh | 8.89 | P/FCF | 105.09 | Sales past 3/5Y | 20.07% 9.96% | ROIC | -20.9% | 52W Low | 133.23% ($39.60) | Perf 3Y | 263.91% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -145.57% | Gross Margin | 97.22% | Volatility(W/M) | 4.69% 4.61% | Perf 5Y | 197.94% |
| Dividend TTM | - | EV/Sales | 115.96 | Sales Y/Y TTM | -89.41% | Oper. Margin | -343.63% | ATR (14) | 4.05 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 12.71 | EPS Q/Q | -134.96% | Profit Margin | -282.83% | RSI (14) | 55.43 | Recom | 1.23 |
| Dividend Gr. 3/5Y | - | Current Ratio | 12.71 | Sales Q/Q | -95.64% | SMA20 | 2.84% ($89.81) | Beta | 2.21 | Target Price | $106.54 |
| Payout | - | Debt/Eq | 0.02 | Earnings | 2000000 | SMA50 | 7.72% ($85.74) | Rel Volume | 1.2 | Prev Close | $95.42 |
| Employees | 132 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | -21.65% -14.92% | SMA200 | 29.15% ($71.51) | Avg Volume(3M) | 0.75M | Price | $92.36 |
| IPO | 2016/8/11 | Option/Short | Yes/Yes | Trades | 13944 | Volume | 896,180 | Change | -3.21% |
뉴스 로딩 중...